BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33670444)

  • 21. Polycomb complex protein BMI1 confers resistance to tamoxifen in estrogen receptor positive breast cancer.
    Ojo D; Lin X; Wu Y; Cockburn J; Bane A; Tang D
    Cancer Lett; 2018 Jul; 426():4-13. PubMed ID: 29626519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sialylation pattern in lung epithelial cell line and Siglecs expression in monocytic THP-1 cells as cellular indicators of cigarette smoke - induced pathology in vitro.
    Wielgat P; Trofimiuk E; Czarnomysy R; Holownia A; Braszko JJ
    Exp Lung Res; 2018 Apr; 44(3):167-177. PubMed ID: 29781747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic organization of the siglec gene locus on chromosome 19q13.4 and cloning of two new siglec pseudogenes.
    Yousef GM; Ordon MH; Foussias G; Diamandis EP
    Gene; 2002 Mar; 286(2):259-70. PubMed ID: 11943481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients.
    Heublein S; Mayr D; Egger M; Karsten U; Goletz S; Angele M; Gallwas J; Jeschke U; Ditsch N
    J Exp Clin Cancer Res; 2015 May; 34(1):50. PubMed ID: 25986064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells.
    Li N; Zhang W; Wan T; Zhang J; Chen T; Yu Y; Wang J; Cao X
    J Biol Chem; 2001 Jul; 276(30):28106-12. PubMed ID: 11358961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer.
    Abduljabbar R; Al-Kaabi MM; Negm OH; Jerjees D; Muftah AA; Mukherjee A; Lai CF; Buluwela L; Ali S; Tighe PJ; Green A; Ellis I; Rakha E
    Breast Cancer Res Treat; 2015 Apr; 150(3):511-22. PubMed ID: 25794775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus.
    Ren X; Ji Y; Jiang X; Qi X
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
    Cao L; Xu C; Xiang G; Liu F; Liu X; Li C; Liu J; Meng Q; Jiao J; Niu Y
    Mol Cancer; 2018 Sep; 17(1):136. PubMed ID: 30217192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily.
    Floyd H; Ni J; Cornish AL; Zeng Z; Liu D; Carter KC; Steel J; Crocker PR
    J Biol Chem; 2000 Jan; 275(2):861-6. PubMed ID: 10625619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs.
    Nguyen DH; Ball ED; Varki A
    Exp Hematol; 2006 Jun; 34(6):728-35. PubMed ID: 16728277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9.
    Rodriguez E; Boelaars K; Brown K; Eveline Li RJ; Kruijssen L; Bruijns SCM; van Ee T; Schetters STT; Crommentuijn MHW; van der Horst JC; van Grieken NCT; van Vliet SJ; Kazemier G; Giovannetti E; Garcia-Vallejo JJ; van Kooyk Y
    Nat Commun; 2021 Feb; 12(1):1270. PubMed ID: 33627655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancer.
    Czogalla B; Kuhn C; Heublein S; Schmöckel E; Mayr D; Kolben T; Trillsch F; Burges A; Mahner S; Jeschke U; Hester A
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2519-2527. PubMed ID: 31485769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2.
    Yu Z; Maoui M; Wu L; Banville D; Shen S
    Biochem J; 2001 Feb; 353(Pt 3):483-92. PubMed ID: 11171044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
    Ikehara Y; Ikehara SK; Paulson JC
    J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulatory activity of extracellular Hsp70 mediated via paired receptors Siglec-5 and Siglec-14.
    Fong JJ; Sreedhara K; Deng L; Varki NM; Angata T; Liu Q; Nizet V; Varki A
    EMBO J; 2015 Nov; 34(22):2775-88. PubMed ID: 26459514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions.
    Suzuki T; Hayashi S; Miki Y; Nakamura Y; Moriya T; Sugawara A; Ishida T; Ohuchi N; Sasano H
    Endocr Relat Cancer; 2006 Mar; 13(1):233-50. PubMed ID: 16601291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer.
    El-Ansari R; Craze ML; Alfarsi L; Soria D; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
    Breast Cancer Res Treat; 2019 May; 175(1):27-38. PubMed ID: 30671766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Siglec-8 in induced sputum of COPD patients.
    Mroz RM; Holownia A; Wielgat P; Sitko A; Skopinski T; Chyczewska E; Braszko JJ
    Adv Exp Med Biol; 2013; 788():19-23. PubMed ID: 23835953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AR pathway activity correlates with AR expression in a HER2-dependent manner and serves as a better prognostic factor in breast cancer.
    Liu D
    Cell Oncol (Dordr); 2020 Apr; 43(2):321-333. PubMed ID: 31933152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties.
    Yu H; Gonzalez-Gil A; Wei Y; Fernandes SM; Porell RN; Vajn K; Paulson JC; Nycholat CM; Schnaar RL
    Glycobiology; 2017 Jul; 27(7):657-668. PubMed ID: 28369504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.